silenan: a pectic polysaccharide from Campion Silene vulgaris (Moench) Garcke [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Silene | genus | A plant genus of the family CARYOPHYLLACEAE. The common name of campion is also used with LYCHNIS. The common name of 'pink' can be confused with other plants.[MeSH] | Caryophyllaceae | A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The species are diverse in appearance and habitat; most have swollen leaf and stem joints.[MeSH] |
| Silene vulgaris | species | [no description available] | Caryophyllaceae | A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The species are diverse in appearance and habitat; most have swollen leaf and stem joints.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 76966388 |
| MeSH ID | M0473689 |
| Synonym |
|---|
| devilan |
| sulfanilamide d-camphorsulfonate |
| I70552426D , |
| sulfanilamide camphorsulfonate |
| 60154-11-2 |
| silenan |
| sulfanilamide camphorsulfonate [who-dd] |
| benzenesulfonamide, 4-amino-, mono((1s)-7,7-dimethyl-2-oxobicyclo(2.2.1)heptane-1-methanesulfonate) |
| unii-i70552426d |
| Q27280519 |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Silenan has been shown to contain homogalacturonan segments as "smooth regions" and rhamnogalacturonan fragments as "hairy regions"." | ( Structure of silenan, a pectic polysaccharide from Campion Silene vulgaris (Moench) Garcke. Bushneva, OA; Chizhov, AO; Ovodov, YS; Ovodova, RG; Shashkov, AS, 2003) | 1.41 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.21) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||